Clinical Computing PLC
01 September 2003
1 September 2003
Clinical Computing Plc ('Clinical Computing' or the 'Company')
Result of Open Offer
On 6 August 2003, Clinical Computing announced the proposed placing of 6,430,051
New Ordinary Shares at 40 pence per share incorporating an Open Offer to
Qualifying Shareholders of 4,180,051 New Ordinary Shares on the basis of 1 New
Ordinary Share for every 6 Existing Ordinary Shares.
The Company announces today that valid acceptances have been received in respect
of 2,223,962 New Ordinary Shares representing a total of 53.2% of those
available under the Open Offer.
Of the valid acceptances, in accordance with their irrevocable undertakings to
take up part of their entitlement, aggregate acceptances in respect of 750,000
New Ordinary Shares have been received from Howard Kitchner and Michael Gordon,
two Directors of the Company, and David Althschuler, a significant shareholder,
representing 17.9% of those New Ordinary Shares available under the Open Offer.
Of the 1,956,089 not taken up under the Open Offer the Directors and Mr
Altschuler irrevocably undertook not to take up in total 947,833 New Ordinary
Shares representing 22.7 per cent. of the total available under the Open Offer.
Shareholders are reminded of the extraordinary general meeting of the Company to
take place at 10.00 am on 1 September 2003 at the office of Investec, 2 Gresham
Street, London EC2V 7QP.
The Placing and Open Offer remain conditional upon admission of the New Ordinary
Shares to the Official List and to trading on the London Stock Exchange's market
for listed securities, which is expected to take place on 2 September 2003.
Enquiries
Clinical Computing plc Tel: 020 8747 8744
Joseph Marlovits, Company Secretary
Investec Investment Banking Tel: 020 7597 5970
Nigel Tose, Co Head of Corporate Finance
Andrew Craig
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.